GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 81 filers reported holding GALENA BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $12,000 | -73.9% | 34,197 | +3.4% | 0.00% | – |
| Q1 2015 | $46,000 | -24.6% | 33,074 | +11.9% | 0.00% | – |
| Q3 2014 | $61,000 | -37.1% | 29,559 | -6.4% | 0.00% | -100.0% |
| Q2 2014 | $97,000 | +32.9% | 31,566 | -2.1% | 0.00% | – |
| Q3 2013 | $73,000 | +180.8% | 32,243 | +180.2% | 0.00% | – |
| Q2 2013 | $26,000 | – | 11,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spark Investment Management LLC | 308,500 | $462,000 | 0.08% |
| Perceptive Advisors | 200,000 | $302,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $45,000 | 0.02% |
| EXANE DERIVATIVES | 100,000 | $150,995,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $30,000 | 0.02% |
| Alyeska Investment Group, L.P. | 530,000 | $801,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $23,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 13,350 | $20,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 458,952 | $693,000 | 0.01% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,605 | $388,000 | 0.01% |